✦ LIBER ✦

Chemotherapy Treatment and Survival in Older Women with Estrogen Receptor–Negative Metastatic Breast Cancer: A Population-Based Analysis

✍ Scribed by Myra Schneider; Ilene H. Zuckerman; Eberechukwu Onukwugha; Naimish Pandya; Brian Seal; Jim Gardner; C. Daniel Mullins

Book ID: 109132640
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 127 KB
Volume: 59
Category: Article
ISSN: 0002-8614
DOI: 10.1111/j.1532-5415.2011.03351.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An estrogen receptor genetic polymorphis

An estrogen receptor genetic polymorphism and a history of spontaneous abortion — Correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer

✍ Steven P. Lehrer; Rita K. Schmutzler; Jill M. Rabin; Beth S. Schachter 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 434 KB

Optimal treatment strategies in postmeno

Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer

✍ Joseph Gligorov; Jean-Pierre Lotz 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 323 KB

Association of estrogen receptor α polym

Association of estrogen receptor α polymorphisms with breast cancer risk in older Caucasian women

✍ Francesmary Modugno; Joseph M. Zmuda; Douglas Potter; Chao Cai; Elad Ziv; Steven 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 114 KB 👁 1 views

## Abstract Estrogens exert their effect on the breast through the estrogen receptor. We prospectively investigated breast cancer risk associated with 2 polymorphic sites in the estrogen receptor alpha gene (__ESR1__). A total of 4,248 Caucasian women from the Study of Osteoporotic Fractures were g

The impact of new chemotherapeutic and h

The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer

✍ Stephen K. Chia; Caroline H. Speers; Yulia D'yachkova; Anna Kang; Suzanne Malfai 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

## Abstract ## BACKGROUND. Over the past decade, a number of new therapeutic agents have become available in the treatment of metastatic breast cancer (MBC). This study characterized the use and assessed the impact on survival of population‐based access to new agents for the treatment of MBC. ##

Chemotherapy use and risk of bone marrow

Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer

✍ Zhannat Nurgalieva; Chih-Chin Liu; Xianglin L. Du 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 182 KB

Descriptive analysis of estrogen recepto

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype : A population-based study from the California cancer Registry

✍ Katrina R. Bauer; Monica Brown; Rosemary D. Cress; Carol A. Parise; Vincent Cagg 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

## Abstract ## BACKGROUND. Tumor markers are becoming increasingly important in breast cancer research because of their impact on prognosis, treatment, and survival, and because of their relation to breast cancer subtypes. The triple‐negative phenotype is important because of its relation to the b